Drag a card by its title · ⚙ to size, swap or remove

The company

OKYO Pharma Limited -

OKYO · Nasdaq

Health CareBiotechnologyNot moving yet

OKYO stood above a rising 150-day average in 5 of the last 52 weekly readings, and has been out of that trend for the last 40 weeks. It is 9.4% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 40
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $272K
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 19 (+7)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 5 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months7

Sale orders, 12 months0

Buyers · sellers6 · 0

Who	Did	Shares	Traded
Rajkumar V. PatilChief Scientific Officer	bought	3,363at $1.49	27 Jul 2026filed 7 Aug 2026
Robert John DempseyCHIEF EXECUTIVE OFFICER	bought	15,000at $1.54	22 Jul 2026filed 7 Aug 2026
Gabriele M. CerroneDirector, 10% owner	bought	22,500at $1.45	21 Jul 2026filed 7 Aug 2026
Flavio MantelliCHIEF MEDICAL OFFICER	bought	20,000at $1.40	21 Jul 2026filed 7 Aug 2026
Gary S. JacobCHIEF DEVELOPMENT OFFICER	bought	3,500at $1.40	21 Jul 2026filed 7 Aug 2026
John P. BrancaccioDirector	bought	5,000at $1.48	21 Jul 2026filed 7 Aug 2026
Gabriele M. CerroneDirector, 10% owner	bought	25,000at $1.40	20 Jul 2026filed 7 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders19+7 on the quarter

New · exited8 · 1

Reported value$9.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Woodline Partners LPadded · filed 14 Aug 2026	3,652,768$5.5M	+5780.0%
Stonepine Capital Management, LLCadded · filed 14 Aug 2026	862,996$1.3M	+12,996+1.5%
Maven Securities LTDreduced · filed 14 Aug 2026	809,317$1.2M	-366,218−31.2%
Balyasny Asset Management L.P.reduced · filed 14 Aug 2026	580,596$871K	-4,200−0.7%
Opaleye Management Inc.new · filed 14 Aug 2026	375,204$563K	+375,204
UBS Group AGreduced · filed 13 Aug 2026	55,009$83K	-4,751−8.0%
XTX Topco Ltdadded · filed 14 Aug 2026	37,769$57K	+117+0.3%
CHOREO, LLCnew · filed 4 Aug 2026	33,255$50K	+33,255
Quantinno Capital Management LPnew · filed 13 Aug 2026	33,255$50K	+33,255
Cerity Partners LLCunchanged · filed 14 Aug 2026	12,812$19K	00.0%